US President George W. Bush on January 31, in his State of the Union address to Congress, created a buzz around biofuels by announcing a…
A lobbying group for French biotech companies has reacted angrily to the surprising acquittal of 49 activists who had demolished field trials of genetically modified…
The World Trade Organization (WTO) has proposed to make permanent a ‘temporary waiver’ under its agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS).…
In an attempt to promote drug development by young and innovative companies in Europe, the London-based European Medicines Agency (EMEA) unveiled a new storefront targeted…
In an unusual alliance, US agbiotech company Monsanto of St. Louis, Missouri, joined environmental group Greenpeace Germany, based in Hamburg, and European Parliament member Hiltrud…
On November 16, the European Commission proposed closing a market authorization hole in Europe by regulating tissue-engineering products as ‘advanced therapies’ rather than medical devices.…
D1 Oils, a London-based company betting on the worldwide, large-scale cultivation and processing of Jatropha curcas plants for the production of biofuels, announced on May…
Negotiations on new documentation requirements governing cross-border transport of genetically modified organisms (GMOs) broke down on June 3 in Montreal, Canada, over objections by Brazil…
On June 6 in the French town of Versailles, the European Commission kicked off a comprehensive €13.5 ($16.4) million research project on the coexistence and…
Companies seeking an extension to their EU-wide drug’s patent protection, should base their calculations on the time of market authorization in Switzerland if that predated…